本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lexeo Therapeutics

3.04
-0.1900-5.88%
盘前:2.99-0.0500-1.64%04:00 EDT
成交量:104.84万
成交额:325.80万
市值:2.49亿
市盈率:-2.65
高:3.22
开:3.22
低:3.04
收:3.23
52周最高:10.99
52周最低:2.98
股本:8,204.63万
流通股本:5,122.95万
量比:0.65
换手率:2.05%
股息:- -
股息率:- -
每股收益(TTM):-1.1457
每股收益(LYR):-1.8634
净资产收益率:-46.76%
总资产收益率:-27.59%
市净率:1.06
市盈率(LYR):-1.63

数据加载中...

2026/05/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/13

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/30

重要事件披露

Form 8-K - Current report
2026/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/05

重要事件披露

Form 8-K - Current report
2026/01/27

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/26

SEC问询函

Form CORRESP - Correspondence